Mark Jesky - Concepedia

Author

Mark Jesky

University of Birmingham

Also Known As

Jesky, Mark, M. Jesky, Mark D Jesky, Mark D. Jesky, Mark David Jesky, Mark Jesky

Publications

935

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Queen Elizabeth Hospital Birmingham Nordic Bioscience (Denmark)University College London NIHR Surgical Reconstruction and Microbiology Research Centre

About

Mark Jesky is an author at University of Birmingham specializing in chronic kidney disease, nephrology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	280
2	Nephrology	4	4	280
3	Pathology	2	2	134
4	Diabetes	1	1	88
5	Immunology	1	1	46

Mark Jesky

Publications

884

Citations

H-Index

Page 1

	Year	Citations
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial Colin A. Hutchison, Paul Cockwell, V. V. Moroz, The Lancet Haematology GlomerulonephritisHemodialysisUrologyRenal FunctionBortezomib-based Chemotherapy	2019	113
Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study Mark Jesky, Mary Ann Dutton, Indranil Dasgupta, PLoS ONE	2016	93
Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease Cristina Beltrami, Kate Simpson, Mark Jesky, American Journal Of Pathology UrologyRenal DiseaseRenal FunctionMedicineDiabetes	2018	88
Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease Anthony Fenton, Mark Jesky, Charles J. Ferro, PLoS ONE	2017	76
Urinary endotrophin predicts disease progression in patients with chronic kidney disease Daniel Guldager Kring Rasmussen, Anthony Fenton, Mark Jesky, Scientific Reports	2017	69
Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK Sharlene A. Greenwood, Hannah Young, Juliet Briggs, The Lancet Digital Health	2023	55
The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol Stephanie Stringer, Praveen Sharma, Mary Ann Dutton, BMC Nephrology	2013	48
Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney Disease Colin A. Hutchison, Anne Burmeister, Stephen J. Harding, Mayo Clinic Proceedings GlomerulonephritisRenal FunctionRenal DiseaseMedicineKidney Failure	2014	46
The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results Praveen Sharma, Thomas Dietrich, Amneet Sidhu, Journal Of Clinical Periodontology	2014	35
Chronic Kidney Disease After Nonrenal Solid Organ Transplantation Chandrashekhar A. Kubal, Paul Cockwell, Bridget Gunson, Transplantation	2012	34

Page 1